An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund, B Heydenreich… - Clinical & …, 2012 - Wiley Online Library
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …
被引用次数：15 相关文章

An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund… - Clinical & …, 2012 - search.ebscohost.com
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

[引用][C] An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for …

C RASK, L LUND, G LUND… - Clinical and …, 2012 - pascal-francis.inist.fr
An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces
allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen …

An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund, B Heydenreich… - Clinical & Experimental …, 2012 - infona.pl
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund, B Heydenreich… - … Allergy: Journal of …, 2012 - europepmc.org
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund, B Heydenreich… - Clinical and …, 2012 - hero.epa.gov
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment …

C Rask, L Lund, G Lund… - … allergy: journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Subcutaneous specific immunotherapy (SCIT) has proven sustained clinical
efficacy against allergy. The recommended regimen for SCIT is a gradual updosing over a …

[引用][C] An alternative allergen: adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for …

C RASK, L LUND, G LUND, B HEYDENREICH… - Clinical and …, 2012 - Blackwell